Connecticut’s cannabis industry has always been tangled in politics, but a new spotlight on State Rep. Juan Candelaria is raising fresh questions about where public service ends and private interests begin.
Candelaria, a longtime supporter of cannabis legalization in Connecticut, played a major role in helping push adult-use marijuana across the finish line. But now, his dual role as both a state legislator and cannabis industry executive is drawing increased scrutiny.
The tension stems from Candelaria’s position as Director of Operations and Sales for The Goods, a licensed Connecticut cannabis company, while also voting on legislation that directly impacts the state’s marijuana market.
That overlap has sparked criticism from industry observers and cannabis advocates who argue the arrangement creates unavoidable conflict-of-interest concerns—especially as lawmakers debate major changes involving market access, licensing, hemp participation, THC caps, and retail expansion.
Supporters argue Candelaria brings valuable real-world industry knowledge into legislative discussions. Critics counter that lawmakers with direct financial ties to cannabis companies should not be shaping rules that could benefit their employers.
The concerns intensified during the latest legislative session, where several cannabis-related bills aimed to reshape the market. Among the most controversial issues were expanded THC beverage limits, the creation of a possible micro-retailer license, and ongoing restrictions that continue to shut hemp farmers out of Connecticut’s adult-use cannabis industry.
For many watching Connecticut’s cannabis rollout, the bigger issue isn’t just one legislator—it’s the broader structure of a tightly controlled market where regulators, lawmakers, and operators often move in overlapping circles.
That perception has fueled growing frustration among smaller businesses, hemp operators, and consumers who believe the state’s cannabis system increasingly favors insiders while limiting broader competition.
Connecticut legalized cannabis with promises of equity, opportunity, and transparency. But years into the rollout, critics say the same questions keep surfacing: Who really benefits from the rules—and who gets left out?
As the cannabis market continues to evolve, public trust may depend less on who supports legalization and more on whether the system can convince people it’s being governed fairly.
Dabbin-Dad Newsroom
